Inflammatory and Immune-Driven Depression: CRP, Biomarkers, and Anti-Inflammatory Treatment Pathways

Inflammation plays a meaningful role in depression for a subset of patients and evidence increasingly supports CRP-guided antidepressant selection. This session reviews inflammatory depression presentations, immune biomarkers, and the mechanisms connecting cytokines to mood disruption. Faculty will discuss anti-inflammatory pharmacotherapies, glutamatergic modulation, microbiome-focused interventions, and lifestyle approaches targeting immune activity. Attendees will learn practical ways to evaluate inflammatory contributors and apply personalized treatment strategies based on emerging biological insights.